Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

28.6%

2 terminated/withdrawn out of 7 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

43%

3 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4

2(33.3%)

N/A

2(33.3%)

Phase 3

1(16.7%)

Phase 2

1(16.7%)

6Total

Phase 4(2)

N/A(2)

Phase 3(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT06516042Phase 3Active Not Recruiting

Targeted Antimalarial Drug Administration for Seasonal Migrant Populations in Amhara Region, Ethiopia

Role: collaborator

NCT04002726Not ApplicableTerminated

App-based Versus Slide-based Inter-grader Agreement (IGA) Test for Trachoma Graders

Role: collaborator

NCT03997487Not ApplicableTerminated

Smartphone App for Taking Images of Conjunctivae

Role: collaborator

NCT03570814Phase 4Completed

Cluster RCT of Co-administration Azithromycin, Albendazole & Ivermectin

Role: collaborator

NCT03813069Phase 2Completed

Testing Insect Repellents Against Musca Sorbens, the Vector of Trachoma

Role: collaborator

NCT04276103Completed

Surgical Assessment Tool for Ethiopia National Policy Monitoring & Evaluation

Role: collaborator

NCT01680406Phase 4Completed

Ethiopia Antimalarial in Vivo Efficacy Study 2012

Role: collaborator

All 7 trials loaded